EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NOX.AX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Noxopharm Limited stock downgraded from Hold/Accumulate to Sell Candidate after Wednesday trading session.
(Updated on Jun 26, 2024)

Sell candidate since Jun 26, 2024 PDF

No changes to the price of Noxopharm Limited stock on the last trading day (Wednesday, 26th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0690 to a day high of $0.0690. The price has been going up and down for this period, and there has been a -1.43% loss for the last 2 weeks.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0690 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.92% during the next 3 months and, with a 90% probability hold a price between $0.0813 and $0.104 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NOX.AX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 13, 2024, and so far it has risen 2.99%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Noxopharm Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0707 and $0.0731. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Noxopharm Limited stock

Noxopharm Limited finds support from accumulated volume at $0.0670 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 5.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NOX.AX) For The Upcoming Trading Day Of Thursday 27th

For the upcoming trading day on Thursday, 27th we expect Noxopharm Limited to open at $0.0690, and during the day (based on 14 day Average True Range), to move between $0.0648 and $0.0732, which gives a possible trading interval of +/-$0.0042 (+/-6.10%) up or down from last closing price. If Noxopharm Limited takes out the full calculated possible swing range there will be an estimated 12.19% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0670 (2.90%) than the resistance at $0.0720 (4.35%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Noxopharm Limited stock A Buy?

The Noxopharm Limited stock holds several negative signals and despite the positive trend, we believe Noxopharm Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.401 Sell Candidate Downgraded

Predicted Opening Price for Noxopharm Limited of Thursday, June 27, 2024

Fair opening price June 27, 2024 Current price
$0.0690 ( 0%) $0.0690

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NOX.AX

Fibonacci Support & Resistance Levels

Level Price
R3 0.0690 -
R2 0.0690 -
R1 0.0690 -
Price 0.0690
S1 0.0690 -
S2 0.0690 -
S3 0.0690 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0840 21.74%
R2 0.0780 13.04%
R1 0.0720 4.35%
Price 0.0690
S1 0.0670 -2.90%
S2 0.0630 -8.70%
S3 0.0600 -13.04%

FAQ

What is the symbol for Noxopharm Limited Stock and on which exchange is it traded?
The symbol for Noxopharm Limited is NOX.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Noxopharm Limited Stock?
The Noxopharm Limited stock holds several negative signals and despite the positive trend, we believe Noxopharm Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Noxopharm Limited Stock?
Noxopharm Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Noxopharm Limited Stock.

What's the current price of Noxopharm Limited Stock?
As of the end of day on the Jun 26, 2024, the price of an Noxopharm Limited (NOX.AX) share was $0.0690.

What is the 52-week high and low for Noxopharm Limited Stock?
The 52-week high for Noxopharm Limited Stock is $0.165 and the 52-week low is $0.0330.

What is the market capitalization of Noxopharm Limited Stock?
As of the Jun 26, 2024, the market capitalization of Noxopharm Limited is 20.164M.

When is the next earnings date for Noxopharm Limited?
The upcoming earnings date for Noxopharm Limited is Jul 11, 2024.
Click to get the best stock tips daily for free!

About Noxopharm Limited

Noxopharm Limited Noxopharm Limited, a drug development company, engages in the research and development of drugs for the treatment of cancer and prevention of septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate ca... NOX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT